Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

Clinical trial NCT01053013 · COMPLETED

Trial details

NCT number: NCT01053013
Sponsor: The Rogosin Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Non-resectable Pancreatic Adenocarcinoma Metastatic Colorectal Cancer Metastatic

Start date: 2010-04-15
Primary completion: 2016-04-16
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.